MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,008,000 | -48.9% | 19,162 | -38.9% | 2.18% | -46.6% |
Q1 2019 | $3,929,000 | +39.1% | 31,356 | +25.1% | 4.08% | +23.0% |
Q4 2018 | $2,825,000 | +51.7% | 25,070 | +188.5% | 3.32% | +124.0% |
Q3 2018 | $1,862,000 | +417.2% | 8,690 | +575.2% | 1.48% | +420.0% |
Q2 2018 | $360,000 | – | 1,287 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PACIFIC VIEW ASSET MANAGEMENT, LLC | 25,070 | $2,825,000 | 3.32% |
HealthCor Management, L.P. | 688,890 | $77,652,000 | 2.43% |
Avoro Capital Advisors LLC | 225,000 | $25,362,000 | 1.52% |
EMORY UNIVERSITY | 17,038 | $1,921,000 | 1.51% |
Rock Springs Capital Management LP | 241,000 | $27,166,000 | 1.28% |
Baker Brothers Advisors | 1,169,278 | $131,801,000 | 1.08% |
Caption Management, LLC | 100,800 | $11,362,000 | 0.91% |
SHIKIAR ASSET MANAGEMENT INC | 14,341 | $1,617,000 | 0.84% |
Pier Capital, LLC | 37,654 | $4,244,000 | 0.84% |
Atika Capital Management LLC | 20,000 | $2,254,000 | 0.66% |